In this free webinar, learn how AI can support, rather than replace, the essential expertise of medical writing teams. Attendees…
With 45-plus locations and more than 225 providers, the physician-owned practice makes it simpler for families to get all the…
Acquisition underscores Infinite Auctions' momentum as 1-of-1 cards of sports legends reach record-breaking values MESA, ARIZONA / ACCESS Newswire /…
Black Book Research survey reveals compliance gaps, weak technology readiness, and mounting patient care risks as Medicare telehealth flexibilities approach…
Breakthrough Therapy designation complements Rusfertide's Orphan Drug and Fast Track designations, which together confer multiple benefits to the development programU.S.…
– Moderated discussion with leading expert in Fibrostenotic Crohn's Disease (FSCD) and Inflammatory Bowel Diseases (IBD), Dr. Brian Feagan –…
Final patient visit marks key milestone for Biofrontera, with top-line results expected Q1 2026Company plans FDA discussion in Q3 2026…
Current Clinical Trial Focus is MSS Colorectal Cancer, Ovarian Clear-Cell Carcinoma, and Soft-Tissue SarcomaDENVER, Aug. 25, 2025 (GLOBE NEWSWIRE) --…
As Part of the Settlement, Lupin Receives a License to Market Generic FIRDAPSE Beginning in February 2035CORAL GABLES, Fla., Aug.…
Company’s pembrolizumab-based immune checkpoint inhibitor exhibited success against solid tumors in IND-enabling studies by simultaneously activating immune cells and promoting their…